×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
TSHA – taysha gene therapies, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
TSHA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/21
01:29 pm
tsha
How FDA Breakthrough Status For TSHA-102 At Taysha Gene Therapies (TSHA) Has Changed Its Investment Story [Yahoo! Finance]
Low
Report
How FDA Breakthrough Status For TSHA-102 At Taysha Gene Therapies (TSHA) Has Changed Its Investment Story [Yahoo! Finance]
3/21
01:31 am
tsha
Taysha Gene Therapies (TSHA) was upgraded by Wall Street Zen from "se
Low
Report
Taysha Gene Therapies (TSHA) was upgraded by Wall Street Zen from "se
3/20
08:05 am
tsha
Taysha Gene Therapies (TSHA) had its price target raised by Needham & Company LLC from $10.00 to $12.00. They now have a "buy" rating on the stock.
Low
Report
Taysha Gene Therapies (TSHA) had its price target raised by Needham & Company LLC from $10.00 to $12.00. They now have a "buy" rating on the stock.
3/20
06:58 am
tsha
Taysha Gene Therapies Reports Full-Year 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
Low
Report
Taysha Gene Therapies Reports Full-Year 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
3/19
03:27 pm
tsha
Taysha Gene Therapies Inc (TSHA) Q4 2025 Earnings Call Highlights: Strong Cash Position and ... [Yahoo! Finance]
Low
Report
Taysha Gene Therapies Inc (TSHA) Q4 2025 Earnings Call Highlights: Strong Cash Position and ... [Yahoo! Finance]
3/19
02:52 pm
tsha
Taysha Gene Therapies (TSHA) had its "buy" rating reaffirmed by Chardan Capital. They now have a $12.00 price target on the stock.
Low
Report
Taysha Gene Therapies (TSHA) had its "buy" rating reaffirmed by Chardan Capital. They now have a $12.00 price target on the stock.
3/19
10:33 am
tsha
Taysha (TSHA) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Taysha (TSHA) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
3/19
08:05 am
tsha
Taysha Gene Therapies GAAP EPS of -$0.34 beats by $0.02, revenue of $9.77M beats by $3.47M [Seeking Alpha]
Low
Report
Taysha Gene Therapies GAAP EPS of -$0.34 beats by $0.02, revenue of $9.77M beats by $3.47M [Seeking Alpha]
Date
Time
Symbol
Company Name
Action
%Chg
3/19/2026
08:00 am
tsha
taysha gene therapies, inc.
MISS
Report
-2.6%
taysha gene therapies, inc.
11/4/2025
07:00 am
tsha
taysha gene therapies, inc.
IN-LINE
Report
-1.8%
taysha gene therapies, inc.
8/12/2025
08:01 am
tsha
taysha gene therapies, inc.
MISS
Report
-3.2%
taysha gene therapies, inc.
5/15/2025
08:00 am
tsha
taysha gene therapies, inc.
IN-LINE
Report
5.8%
taysha gene therapies, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/19
08:32 am
tsha
Form 10-K Taysha Gene Therapies, For: Dec 31
Low
Report
Form 10-K Taysha Gene Therapies, For: Dec 31
3/19
08:08 am
tsha
Form 8-K Taysha Gene Therapies, For: Mar 19
Low
Report
Form 8-K Taysha Gene Therapies, For: Mar 19
2/27
04:11 pm
tsha
Form 144 Taysha Gene Therapies, Filed by: Haque-Ahmed Rumana
Neutral
Report
Form 144 Taysha Gene Therapies, Filed by: Haque-Ahmed Rumana
2/17
04:09 pm
tsha
Form SCHEDULE 13G Taysha Gene Therapies, Filed by: Vestal Point Capital, LP
Low
Report
Form SCHEDULE 13G Taysha Gene Therapies, Filed by: Vestal Point Capital, LP
2/17
08:49 am
tsha
Form SCHEDULE 13G/A Taysha Gene Therapies, Filed by: RTW INVESTMENTS, LP
Low
Report
Form SCHEDULE 13G/A Taysha Gene Therapies, Filed by: RTW INVESTMENTS, LP
2/6
04:31 pm
tsha
Form 4 Taysha Gene Therapies, For: Feb 04 Filed by: Alam Kamran
Neutral
Report
Form 4 Taysha Gene Therapies, For: Feb 04 Filed by: Alam Kamran
2/5
01:40 pm
tsha
Form SCHEDULE 13G/A Taysha Gene Therapies, Filed by: FMR LLC
Low
Report
Form SCHEDULE 13G/A Taysha Gene Therapies, Filed by: FMR LLC
2/4
06:44 pm
tsha
Form 144 Taysha Gene Therapies, Filed by: McGinnis Emily
Low
Report
Form 144 Taysha Gene Therapies, Filed by: McGinnis Emily
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: